TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Galecto Biotech AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
8,123 |
| Financial expenses |
355
|
1,871
|
7,380 |
| Earnings before taxes |
-7,197
|
-227,828
|
-373,552 |
| EBITDA |
-6,842
|
-227,381
|
-366,908 |
| Total assets |
6,124
|
61,054
|
132,244 |
| Current assets |
4,130
|
31,973
|
95,248 |
| Current liabilities |
5,354
|
47,840
|
113,880 |
| Equity capital |
770
|
13,214
|
18,364 |
| - share capital |
158
|
1,811
|
1,806 |
| Employees (average) |
1
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
12.6%
|
21.6%
|
13.9% |
| Turnover per employee |
0
|
0
|
4,062 |
| Profit as a percentage of turnover | -4598.7% | ||
| Return on assets (ROA) |
-111.7%
|
-370.1%
|
-276.9% |
| Current ratio |
77.1%
|
66.8%
|
83.6% |
| Return on equity (ROE) |
-934.7%
|
-1724.1%
|
-2034.2% |
| Change turnover |
0
|
-8,165
|
8,123 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-50%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.